IGeneX
PrivateLast Round
Buyout/LBO
Sep 17, 2015
Company Overview
IGeneX operates in Healthcare & Life Sciences and is based in Milpitas, California. It was founded in 1991.
IGeneX is a biotechnology company that provides specialized laboratory diagnostic testing services for Lyme disease and other tick-borne illnesses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IGeneX Comparables
Compare IGeneX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galaxy Diagnostics, Inc. | 89% | |
| T Lab Inc. | 79% | |
| ArminLabs | 77% |
For institutional investors. Book with your work email.
IGeneX Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
IGeneX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balance Point Capital | Buyout/LBO |
| 4C Capital | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 31% MoM to 28.4K.
- Sep 17, 2015
Led by 4C Capital and Balance Point Capital.
For institutional investors. Book with your work email.
IGeneX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IGeneX's valuation, stock price, and market status.
Is IGeneX a public or private company?
IGeneX is a private company.
What is the current stock price of IGeneX?
IGeneX is a private company, so its shares have no public market price. Caplight tracks IGeneX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IGeneX worth (valuation)?
Valuation information for IGeneX is not publicly available.
Can I buy IGeneX stock?
IGeneX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IGeneX's last funding round?
IGeneX's most recent funding round was Buyout/LBO on September 17, 2015.
Who are the main investors in IGeneX?
Key investors in IGeneX include Balance Point Capital, 4C Capital.
Will IGeneX IPO soon?
No public IPO plans have been announced for IGeneX.
How can I track IGeneX secondary market activity?
Caplight tracks bids, offers, and trades in IGeneX's shares on secondary markets.